Maintaining healthy lipid metabolism and vascular function*
GLP-1 receptor activation appears to release the accelerator (reducing inflammatory effector cells) while strengthening the brake (enhancing regulatory cells)
A gastroenterologist explains this well: "The same sense of fullness, or 'early satiety,' that prevents overeating can also slow the gut down" [9]
Daphnes dedication to her craft and her patients has made her a trusted figure in both the medical and aesthetic communities
Kim DW, Tan EY, Jin Y et al , Effects of imatinib mesylate on the pharmacokinetics of paracetamol (acetaminophen) in Korean patients with chronic myelogenous leukaemia
Patients with certain medical conditions, such as gastrointestinal issues (e.g., gastroparesis) or a history of pancreatitis, may not be good candidates for GLP-1 treatment